BACKGROUND: the transforming growth factor-bsignaling pathway has been identified as being involved in colorectal cancer.
t he transforming growth factor-b (tGF-b)-signaling pathway is involved in all aspects of tumorigenesis, including cell growth regulation, avoidance of apoptosis, promotion of inflammation and angiogenesis, immune response, and stimulation of tumor invasion and metastasis. 1 A functional tGF-b-signaling pathway can restrict cell growth by inhibiting cell proliferation, mediating differentiation and inducing apoptosis; a dysfunctional tGF-b-signaling pathway is associated with cancer development, progression, and metastasis.
2 the tGF-b cytokine family includes bone morphogenetic proteins (BmPs), which have been independently associated with colon and rectal cancer. 3 regulation of tGF-b signaling involves interaction with Smad proteins and runt-related transcription factors (rUnx), including RUNX1, RUNX2, and RUNX3. [4] [5] [6] tGF-b signaling also entails non-Smad pathways that include mitogen-activated protein kinase 1 (mAPk1), also known as extracellular signal-regulated kinase 2, eukaryotic translation initiation factor 4E (eiF4E), 7 nuclear factor-kB (nFkB), and the Akt pathway including phosphatase and tensin homologue (PtEn) and mammalian target of rapamycin (mtor). [8] [9] [10] the importance of the tGF-b-signaling pathway in colon and rectal cancer has been supported in numerous studies. recent gene-set analysis of genome-wide association study colon cancer data have identified it as a key pathway associated with colon cancer. 11 our previous work further demonstrates the risk associated with genetic variation in components of this pathway with colon and rectal cancer. 3, [12] [13] [14] [15] Given the importance of this pathway in colon and rectal cancer, it is reasonable to determine whether lifestyle factors impact the susceptibility associated with genetic risk. Given the biological function of the pathway, it is possible that lifestyle factors that influence inflammation, insulin, or energy-related factors may importantly modify genetic risk. Factors previously identified with colon and rectal cancer risk that may influence this pathway are use of aspirin/nonsteroidal anti-inflammatory drugs (nSAiDs), estrogen status, use of cigarettes, body size, physical activity, and dietary intake. [16] [17] [18] [19] [20] [21] [22] [23] our goal in this study is to evaluate the association of the composite genetic variation in the tGF-b-signaling pathway with risk of colon and rectal cancer. to do this we have developed a genotype risk score that summarizes individual risk across genotypes in the pathway that were associated individually with colon and rectal cancer risk. Similarly, we have summarized individual lifestyle risk through a composite score of those lifestyle variables that independently influenced colon and rectal cancer risk. We evaluate the composite genotype and lifestyle scores as they relate to colon and rectal cancer and to each other to more comprehensively describe the association between the tGF-b-signaling pathway and colon and rectal cancer.
METHODS
two study populations are included in these analyses. the first study, a population-based case-control study of colon cancer, included patients (n  1558) and controls (n  1958), identified between october 1, 1991 and September 30, 1994, who lived in the twin Cities metropolitan Area of minnesota, kaiser Permanente medical Care Program of northern California, and a 7-county area of Utah, and who had complete genotype data. the second study, with identical data collection methods, included patients with cancer of the rectosigmoid junction or rectum (n  756) and controls (n  962) who were identified between may 1997 and may 2001 in Utah and kaiser Permanente medical Care Program of northern California 21 with complete genotype data. Eligible patients were between 30-and 79-years-old at the time of diagnosis, spoke English, were mentally competent to complete the interview, and had no previous history of CrC and no known (as indicated on the pathology report) familial adenomatous polyposis, ulcerative colitis, or Crohn's disease. Approximately 91% of the patients in the colon cancer study and 88% of the patients in the rectal cancer study were non-Hispanic white.
TagSNP Selection and Genotyping
DnA for genotyping was available from buffy coats (California and minnesota) and immortalized cell lines (Utah) for both cases and controls. tagSnPs were selected by the use of the following parameters: r 2  0.8 defined linkage disequilibrium (LD) blocks using a white LD map, minor allele frequency .0.1, range  [minus]1500 bp from the initiation codon to 1500 bp from the termination codon, and 1 single-nucleotide polymorphism (SnP)/LD bin. All markers were genotyped by use of a multiplexed bead array assay format based on GoldenGate chemistry (illumina, San Diego, CA). A genotyping call rate of 99.85% was attained. Blinded internal replicates represented 4.4% of the sample set. the duplicate concordance rate was 100.00%.
For TGFb1, representative markers rs4803455 and rs1800469 were chosen based on a prevalent minor allele frequency and previous findings described in the literature. 24 they were genotyped by use of a taqman assay from Applied Biosystems (Foster City, CA). Each 5-μL polymerase chain reaction (PCr) contained 20 ng of genomic DnA, primers, probes, and taqman Universal PCr master mix (containing AmpErase uracil N-glycosylase, Amplitaq Gold enzyme, dntPs, and reaction buffer). PCr was performed under the following conditions: 50°C for 2 minutes to activate uracil N-glycosylase, 95°C for 10 minutes, followed by 40 cycles of 92°C for 15 seconds, and 60°C for 1 minute with the use of a 384-well dual-block ABi 9700. Fluorescent end points of the taqman reactions were measured by using a 7900Ht sequence detection instrument.
Environmental Data trained and certified interviewers collected diet and lifestyle data as previously outlined. 25, 26 the referent year for the study was the calendar year approximately 2 years before the date of diagnosis (cases) or selection (controls). information on the following demographic factors was collected and assessed: age, sex, and study center; diet, physical activity, regular use of aspirin and nonsteroidal drug use; measured and self-reported height and weight; and other lifestyle factors including medical, family history of first-degree relatives with colorectal cancer, and reproductive history. Physical activity data included information on amount, frequency, and intensity of activities for the referent year, and for 10 and 20 years before the referent year, as well. 27 Dietary data were based on the CArDiA diet history questionnaire. 26, 28 Cigarette-smoking patterns were determined through questions that focused on the age at which patients first started smoking cigarettes, the age at which they stopped cigarette smoking, and the number of cigarettes usually smoked. All data were collected in a rigorous manner with the use of quality control procedures that included review of audiotapes of 10% of interviews as well as any interview in which the interview reported that the respondent provided questionable data.
We focused the analysis on those variables that have been previously associated with colon and rectal cancer. recent use of aspirin/nSAiD, long-term physical activity, cigarette smoking, and Western dietary pattern have been reported as associated with both colon and rectal cancer. 19, 21 For colon cancer we included prudent dietary pattern and Bmi, taking into account the estrogen status of women. 23 For rectal cancer we included dietary fiber and calcium rather than the prudent dietary pattern, because these factors appeared to be more strongly associated with rectal cancer risk than the prudent dietary pattern. Dietary factors including Western and prudent diet, calcium, and fiber were categorized into 3 levels: low, intermediate (2 midquartiles), and high.
Statistical Methods
All statistical analyses were performed by using SAS version 9.2 (SAS institute, Cary, nC). SnP selection was based on previously reported significant associations between genes in the pathway and risk of colon and rectal cancer. Genes included were TGFb1 (2 SnPs), TGFbR1 (3 SnPs), Smad1 (5 SnPs), Smad2 (4 SnPs), Smad3 (37 SnPs), Smad4 (2 SnPs), Smad7 (11 SnPs), BMP1 (11 SnPs), BMP2 (5 SnPs), BMP4 (3 SnPs), BMPR1A (9 SnPs), BMPR1B (21 SnPs), BMPR2 (11 SnPs), GDF10 (7 SnPs), RUNX1 (40 SnPs), RUNX2 (19 SnPs), RUNX3 (9 SnPs), eiF4E (3 SnPs), eiF4EBP2 (2 SnPs), eiF4EBP3 (2 SnPs), and MAPK1 (6 SnPs), NFkB1 (13 SnPs); PTEN (5 SnPs), FRAP1 (3SnPs), and AKT1 (2 SnPs).
to summarize risk associated with multiple variants across the pathway, we created a summary polygenic score 29 that was based on all at-risk genotypes identified from previous analyses for colon and rectal cancer. the score for each SnP was based on the inheritance model and its associated risk. All genotypes were evaluated so that they were coded with the low-risk genotype as 0. For the codominant or additive model, a score of 0, 1, or 2 was assigned directly correlated to the number of high-risk alleles, whereas scores of 0 or 2 were assigned for the dominant and recessive models. For instance, a genotype that was directly associated with risk would be scored 0 for wild type, 1 for heterozygote, and 2 for homozygote variant in the codominant model. if the association were recessive, it would be coded either 0 or 2. in the instance of an inverse association, the wild type would be coded 2, whereas the homozygote variant would be coded as a 0. After assigning a score for each SnP previously identified as being significant, the scores were summed across SnPs to generate an individual polygenic summary score. individuals missing SnP data were dropped from the analysis. For the colon cancer study, this represented 2.3% of all participants, whereas for the rectal cancer study, 6.2% of participants were dropped because they were missing complete genotype data. the continuous score variable was redefined as a categorical variable based on the frequency distribution within the study population. Cut points were used that would allow at least 10% of the population in any category for analysis. only one SnP was used in instances where in high linkage disequilibrium was detected (r 2 . 0.70) Lifestyle factors were selected based on variables previously identified as contributing to risk in these studies. Summary scores were developed for lifestyle factors in a similar manner as we did for genotype summary scores. Lifestyle factors were assigned values of 0, 1, or 2, depending on their risk. For instance, the physical activity variable was assigned a risk of 2 if no lifetime activity was reported (the high-risk lifestyle factor), 1 if they were intermediary, and 0 if they were in the top range of physical activity. For dichotomous variables such as recent nSAiD use, a 2 was assigned for nonusers and 0 for users. Cigarette smoking was categorized based on usual amount used for colon cancer and pack-years of cigarettes smoked for rectal cancer. those who smoked the most, 20 or more cigarettes a day or 20 or more pack-years were assigned a 2, those who never smoked were assigned 0, those who smoked less than 20 cigarettes a day or 20 pack-years were assigned a 1.
or and 95% Cis were estimated from multiple logistic regression models adjusting for age, sex, center, and race. Categories of exposure for summary scores were based on the distribution of the population, with most of the population being in the middle of the distribution which followed a bell-shaped curve. our goal was to have close to a 10% sample in all categories to provide stability to risk estimates. Linear trend was based on the improved fit of the model when the score variables were treated as continuous. p values for interaction were calculated for both the continuous and categorical models by comparing a full model that included an interaction term with a reduced model without an interaction term by using a likelihood ratio test.
RESULTS
SnPs contributing to colon and rectal cancer risk are shown in table 1. For colon cancer, 16 genes and 35 SnPs were statistically significantly associated with colon cancer after adjustment for age, sex, center, and race. Fewer genes were associated with rectal cancer. We observed that 11 genes and 18 SnPs significantly altered risk of rectal cancer. For the most part, the SnPs that were most important for colon and rectal cancer differed. BMP2 rs3178250 and RUNX3 rs6672420 were associated with both colon and rectal cancer, although the associations were in the opposite directions for RUNX3 rs6672420. A statistically significant linear trend for increasing risk with increasing mutational load was seen for both colon and rectal cancer (p  0.0001) (table 2). more than a 3-fold increase in risk was observed for both diseases at the highest category of high-risk genotypes. Similarly, if one looked at summary of risk associated with lifestyle factors, a 3-fold increase in risk was associated with both colon cancer and rectal cancer. Again, significant linear trend was observed for both colon and rectal cancer that showed increasing risk with number of "at-risk" lifestyle factors.
We observed a statistically significant interaction between lifestyle score and genotype score for colon cancer on the categorical interaction (p  0.001) but not continuous variable interaction (p  0.745); for rectal cancer the p value for interaction was 0.157 for categorical and 0.760 for continuous) (Fig. 1) . the magnitude of the combined risk was similar for both colon and rectal cancer. For colon cancer, those with the highest genotype and lifestyle score had an or of 7.89 (95% Ci 4.45, 13.96); for rectal cancer, the estimate of association was 8.75 (95% Ci 3.66, 20.89).
We further stratified the data on 3 lifestyle factors that have been previously shown to interact with TGFb1 and are associated with both colon and rectal cancer (table 3) , recent use of nSAiDs, exposure to cigarette smoke, and recent exposure to estrogen. Although statistically significant interactions were not observed, clear patterns of associations emerged for all 3 factors. For those protective factors, nSAiDs and recent estrogen exposure, there is reduced risk of both colon and rectal cancer at low genotype scores where individuals have the fewest "at-risk" genotypes. As the genotype score increases with increasing number of "at-risk" genotypes, the risk increases and becomes significant at the third or fourth category of genotype score, but the risk is less than for those exposed to nSAiDs or estrogen than without the exposure. For cigarette-smoking exposure, the risk associated with high-risk genotype score is less for nonsmokers than for those who smoke cigarettes.
interaction between Bmi, physical activity, and dietary factors with polygenic risk is shown in table 4. For colon cancer, the risk from being obese increased with increasing genotype risk. Physical activity and prudent diet had minimal effect on modifying risk from the high-risk genotype. Western diet appeared to have the strongest interaction with the polygenic risk summary score. Eating a diet that strongly followed the Western dietary pattern increased risk of colon and rectal cancer the most as genotype risk increased.
DISCUSSION
the importance of the tGF-b-signaling pathway in the origin of colon and rectal cancer is well recognized. in this study, we have shown that numerous components of the pathway contribute independently to colon and rectal cancer risk, and that risk increases with increasing genetic susceptibility. Likewise, lifestyle factors play an important role in the composite risk. our data suggest that while lifestyle factors can modify risk of colon and rectal cancer at low levels of genetic risk, they lose their protective benefits when high levels of genetic risk exist.
We have used a candidate pathway approach, identifying genetic variants in components of the tGF-b-signaling pathway that involves BMP, RUNX, MAPK1, eIF4E, and Smad as well as the non-Smad-related signaling regulators that include AKT, PTEN, mTOR, and NFkB1. With the use of this candidate pathway approach, we identified genetic variants that independently influenced colon and rectal cancer risk after consideration of other genes in the pathway. Given our goal of identifying composite risk associated with the pathway, we developed a polygenic risk score that took into account the most appropriate model of inheritance and the number of "at-risk" alleles for each individual. refinement of the score, taking into account the ratio of the strength of the association by using the b-coefficient for each SnP and the precision of the estimate by factoring in the variance associated with each individual SnP, did not appreciably alter the risk estimates presented. thus, we present data from the simpler method of calculation that assigns risk based on number of at-risk alleles for each genotype that independently were associated with colon and rectal cancer. A limitation is that individuals without complete data were dropped from the analysis. However, the numbers excluded because of incomplete genotype data are few and were dropped nondifferentially between cases and controls.
in contrast to our approach, others have used geneset analysis as a method to identify important disease pathways. 13 Although we hypothesized that the tGF-bsignaling pathway was important, others have identified it as important by the use of the gene-set analysis approach.
11 this supports our hypothesis of the importance of the pathway. Although the gene-set analysis returns a p value that shows the degree of statistical significance, our approach has been to identify the magnitude of the association with the pathway, reporting risk estimates and 95% Cis associated with those estimates. in doing this, it should be recognized that cut points are arbitrary, resulting in estimates of association varying depending on where cut points are set. our goal was to establish a referent group with stability for estimation of risk; thus, we targeted approximately the bottom 10% of the distribution as those with lowest genetic risk. However, despite the variation in exact risk estimate based on cut points, a significant linear trend observed across all cut points evaluated suggests that mutational load is important in a linear fashion. it also is of interest to note that, despite variation in ors based on cut points, the lower bound of the Ci remained consistent, providing additional support for the estimated association.
our approach has many advantages as a way to estimate the magnitude of risk and consolidate data across a candidate pathway. this approach has reduced the number of individual comparisons with diet and lifestyle factors. We have estimated the magnitude of the association, not just a p value for significance. We have focused on the pathway as important, rather than tagSnPs, for which we have limited information on their functionality. our composite score provides a tool to evaluate how the pathway interacts with lifestyle factors, under the hypothesis that the candidate pathway is the primary object of importance.
our identified composite lifestyle risk was of a magnitude similar to that observed with our composite genotype risk. By looking at these factors together, we increase our understanding of the importance of lifestyle factors in modifying the risk associated with genetic factors. For both colon and rectal cancer, associations were stronger for genotype score than for lifestyle, although having the high-risk score of both resulted in risk that was greater than additive for the independent risk. We further examined 3 lifestyle factors that have previously been identified as independently interacting with specific genotypes within the pathway, nSAiDs, estrogen status, and cigarette smoking. Both nSAiD and estrogen reduced the risk associated with genetic risk. this was most evident at low levels of genetic risk. Likewise, cigarette smoking increased risk at every level of genotype risk, except at the highest level of risk. this implies that lifestyle factors are important in reducing inherited genetic susceptibility. Unfortunately, when the genetic risk is more extreme, the lifestyle factors have less effect. this is in line with inherited susceptibility associated with APC or BRCA1, where the lifestyle and environmental factors cannot offset the inherited risk.
CONCLUSIONS
our data support the importance of the tGF-b-signaling pathway in the origin of colon and rectal cancer. our data suggest that risk increases with increasing number of deleterious variations resulting in an overall unstable or dysfunctional pathway. our results further suggest that the integrity of the pathway, although diminished with additional at-risk genotypes, can in part be offset by lifestyle factors. these findings need replication in other studies. 
